3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
34
Leukemia
15
Gastrointestinal Stromal Tumors
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myeloid, Chronic-Phase
7
Philadelphia Chromosome
4
Leukemia, Myeloid
4
Bone Marrow Diseases
4
Neoplasms
3
Myeloproliferative Disorders
3
Hematologic Diseases
3
Melanoma
2
Hematologic Neoplasms
2
Bronchiolitis Obliterans Syndrome
2
Blast Crisis
2
Synovitis, Pigmented Villonodular
1
Recurrence
1
Piebaldism
1
Peritoneal Neoplasms
1
Ovarian Neoplasms
1
Neurofibromatoses
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplastic Processes
1
Neoplasms by Histologic Type
1
Neoplasm Metastasis
1
Mastocytosis, Systemic
1
Leukemia, Myeloid, Accelerated Phase
1
Hypereosinophilic Syndrome
1
Glioma
1
Interventions
Doxorubicin
6
pazopanib
5
Trabectedin
4
Radiotherapy
3
temsirolimus
2
eribulin
2
Sunitinib
2
Radiotherapy, Conformal
2
Ifosfamide
2
Dexamethasone
2
sitravatinib
1
selinexor
1
saracatinib
1
romidepsin
1
regorafenib
1
plitidepsin
1
pembrolizumab
1
palbociclib
1
olaratumab
1
milademetan
1
liposomal doxorubicin
1
lenvatinib
1
indolepropanol phosphate
1
efatutazone
1
cixutumumab
1
brigimadlin
1
avelumab
1
atezolizumab
1
Watchful Waiting
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Liposarcoma
×
nilotinib
×
Clear all
No trials found.